ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim

Amarin has shored up additional data to back its Vascepa pill to protect against heart problems in patients who’ve already had a heart attack. But piling up more prevention evidence might not help much if the company can’t fight off a cheap generic that’s targeting a smaller indication.